The Proteomic Based Drug Discovery Summit 2025 focuses on harnessing proteomics to accelerate drug development, from hit screening to in vivo translation, and leveraging the proteome to develop more effective therapies.
Topics
- Enhancing Mass Spectrometry Through Optimized DIA & TMT Workflows to Balance Speed & Sensitivity for Reliable Workflows
- Optimizing Proteomics Approaches for Covalent Drug Discovery: Addressing Specificity, Probe Development, & Metabolite Challenges
- Unveiling Protein-Protein Interactions: Advancing Protein Complex Studies Through Translational Proteomic for Informing Drug Development
- Advancing Proteomic Approaches for the Discovery & Development of Proximity-Based Therapeutics for Improved Molecular Glue Degraders
- Advancing a Chemoproteomic Toolkit for Enhance the Discovery of "Ligandable" Residues for Targeting by Small Molecule Drugs
- Enhancing Proteomics Workflows: Merging Discovery & Structural Insights to Enhance Drug Discovery & Development
- Innovative Approaches to Target Engagement: From CNS-Penetrant Degraders to High- Throughput Proteomic Readouts
- Unravel Binding Profiles Through Hydrogen/Deuterium Exchange & Ubiquitin-Specific Proximity Labeling Approaches for Advancing Drug Discovery & Development
